Literature DB >> 12212793

Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers.

Jiaxin Yu1, Lara Bakhos, Lei Chang, Mark J Holterman, William L Klein, Duane L Venton.   

Abstract

Alzheimer's disease is the most common cause of dementia in older individuals with compelling evidence favoring neuron dysfunction and death triggered by assembled forms of A beta(1-42). While large neurotoxic amyloid fibrils have been known for years, recent studies show that soluble protofibril and A beta(1-42)-derived diffusible ligands (ADDLs) may also be involved in neurotoxicity. In the present work, dot-blot immunoassays discriminating ADDLs from monomers were used to screen libraries of per-substituted beta-cyclodextrin (beta-CD) derivatives for inhibition of ADDLs formation. Libraries were prepared from per-6-iodo-beta-CD by treatment with various amine nucleophiles. The most active library tested (containing >2000 derivatives) was derived from imidazole, N, N-dimethylethylenediamine and furfurylamine, which at 10 microM total library, inhibited ADDLs formation (10 nM A beta(1-42)) over a period of 4 hours. The latter was confirmed by a western blot assay showing decreased amounts of the initially formed A beta(1-42) tetramer. These preliminary experiments suggest that derivatized forms of beta-CD can interfere with the oligomerization process of A beta(1-42).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212793     DOI: 10.1007/s12031-002-0010-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Solvent effects on beta protein toxicity in vivo.

Authors:  J Waite; G M Cole; S A Frautschy; D J Connor; L J Thal
Journal:  Neurobiol Aging       Date:  1992 Sep-Oct       Impact factor: 4.673

3.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Combinatorial search of substituted beta-cyclodextrins for phosphatase-like activity.

Authors:  J Yu; Y Zhao; M J Holterman; D L Venton
Journal:  Bioorg Med Chem Lett       Date:  1999-09-20       Impact factor: 2.823

5.  Serpins inhibit the toxicity of amyloid peptides.

Authors:  D Schubert
Journal:  Eur J Neurosci       Date:  1997-04       Impact factor: 3.386

Review 6.  Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

Authors:  T E Golde; C B Eckman; S G Younkin
Journal:  Biochim Biophys Acta       Date:  2000-07-26

7.  Inhibition of Alzheimer beta-fibrillogenesis by melatonin.

Authors:  M Pappolla; P Bozner; C Soto; H Shao; N K Robakis; M Zagorski; B Frangione; J Ghiso
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

8.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

9.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

10.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

View more
  4 in total

1.  Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal.

Authors:  Jason Pitt; William Roth; Pascale Lacor; Amos B Smith; Matthew Blankenship; Pauline Velasco; Fernanda De Felice; Paul Breslin; William L Klein
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-23       Impact factor: 4.219

Review 2.  Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly.

Authors:  Laramie P Jameson; Nicholas W Smith; Sergei V Dzyuba
Journal:  ACS Chem Neurosci       Date:  2012-08-06       Impact factor: 4.418

3.  Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening.

Authors:  Lei Chang; Lara Bakhos; Zhiqiang Wang; Duane L Venton; William L Klein
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

4.  The Third Transmembrane Domain of EscR Is Critical for Function of the Enteropathogenic Escherichia coli Type III Secretion System.

Authors:  Irit Tseytin; Adi Madar; Bosko Mitrovic; Wanyin Deng; B Brett Finlay; Neta Sal-Man
Journal:  mSphere       Date:  2018-07-25       Impact factor: 4.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.